Type your tag names separated by a space and hit enter

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects ID - 455221 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455221/all/First_trimester_use_of_selective_serotonin_reuptake_inhibitors_and_the_risk_of_birth_defects PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -